Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
life sciences
national blog main
biotech
boston blog main
boston top stories
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
23andme
abbvie
acorda therapeutics
aimmune therapeutics
allergy
amgen
ampyra
anaphylaxis
andrew oxtoby
apokyn
apomorphine
archive
bio
biology
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
dalfampridine
daniel edelman
detroit blog main
detroit top stories
drugs
duopa
eli lilly
eosinophilic esophagitis
episodic migraine
food allergy
What
fda
6
×
late
6
×
drug
approval
approved
including
andme
developed
disease
diseases
friday
genes
genetic
medications
medicines
new
onset
parkinson’s
tell
tests
won
ability
accompanying
acorda
administration
advisory
agency
aimmune
allergy
allowed
alzheimers
alzheimer’s
analysis
andme’s
announced
associated
awarded
celiac
children’s
class
Language
unset
Current search:
late
×
fda
×
@slashgear.com
3 years ago
Popular children’s medicines recalled, but not for the reason you think
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@techcrunch.com
7 years ago
23andMe is finally allowed to tell you if you have the genes for Parkinsons
@theverge.com
7 years ago
No doctor required: 23andMe cleared by FDA for at-home DNA tests